These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 1688295)
21. From the Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. JAMA; 1991 Apr; 265(13):1637-40, 1643-4. PubMed ID: 1672167 [No Abstract] [Full Text] [Related]
22. Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy. Esposito S; Bojanin J; Porta A; Cesati L; Gualtieri L; Principi N Pediatr Infect Dis J; 2005 Dec; 24(12):1117-20. PubMed ID: 16371882 [TBL] [Abstract][Full Text] [Related]
23. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA Ann Intern Med; 1992 Jul; 117(2):106-11. PubMed ID: 1351371 [TBL] [Abstract][Full Text] [Related]
24. Therapy of pneumocystis carinii pneumonia after trimethoprim-sulfamethoxazole desensitization. Papakonstantinou G; Füessl H; Matuschke A; Hehlmann R Klin Wochenschr; 1989 Mar; 67(5):316. PubMed ID: 2785231 [No Abstract] [Full Text] [Related]
25. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Antipneumocystis Prophylaxis in Patients with Human Immunodeficiency Virus Infection. J Acquir Immune Defic Syndr (1988); 1993 Jan; 6(1):46-55. PubMed ID: 8417174 [No Abstract] [Full Text] [Related]
26. Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia. White MV; Haddad ZH; Brunner E; Sainz C Ann Allergy; 1989 Mar; 62(3):177-9. PubMed ID: 2522290 [TBL] [Abstract][Full Text] [Related]
27. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. MMWR Recomm Rep; 1991 Mar; 40(RR-2):1-13. PubMed ID: 1672036 [TBL] [Abstract][Full Text] [Related]
28. Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole. Douglas R; Spelman D; Czarny D; O'Hehir RE Clin Infect Dis; 1997 Dec; 25(6):1480. PubMed ID: 9431406 [No Abstract] [Full Text] [Related]
29. A 5-day course of oral desensitization to trimethoprim/sulfamethoxazole (T/S) in patients with human immunodeficiency virus type-1 infection who were previously intolerant to T/S. Yoshizawa S; Yasuoka A; Kikuchi Y; Honda M; Gatanaga H; Tachikawa N; Hirabayashi Y; Oka S Ann Allergy Asthma Immunol; 2000 Sep; 85(3):241-4. PubMed ID: 11030281 [TBL] [Abstract][Full Text] [Related]
30. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review. Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390 [TBL] [Abstract][Full Text] [Related]
31. From the Centers for Disease Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with HIV. JAMA; 1992 May; 267(17):2294-6, 2298-9. PubMed ID: 1348788 [No Abstract] [Full Text] [Related]
32. Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia. Blum RN; Miller LA; Gaggini LC; Cohn DL J Acquir Immune Defic Syndr (1988); 1992; 5(4):341-7. PubMed ID: 1548570 [TBL] [Abstract][Full Text] [Related]
33. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR Recomm Rep; 1992 Apr; 41(RR-4):1-11. PubMed ID: 1348843 [TBL] [Abstract][Full Text] [Related]
34. Prevention and treatment of Pneumocystis carinii pneumonia in patients infected with HIV. Drug Ther Bull; 1994 Feb; 32(2):12-5. PubMed ID: 7654282 [TBL] [Abstract][Full Text] [Related]
35. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole. Lin D; Li WK; Rieder MJ Cochrane Database Syst Rev; 2007 Apr; (2):CD005646. PubMed ID: 17443608 [TBL] [Abstract][Full Text] [Related]
36. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group. Chaisson RE; Keruly J; Richman DD; Moore RD Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus. Caumes E; Guermonprez G; Lecomte C; Katlama C; Bricaire F Arch Dermatol; 1997 Apr; 133(4):465-9. PubMed ID: 9126010 [TBL] [Abstract][Full Text] [Related]
38. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group. Safrin S; Finkelstein DM; Feinberg J; Frame P; Simpson G; Wu A; Cheung T; Soeiro R; Hojczyk P; Black JR Ann Intern Med; 1996 May; 124(9):792-802. PubMed ID: 8610948 [TBL] [Abstract][Full Text] [Related]
39. [A case report of acquired immunodeficiency syndrome (AIDS) with hypersensitivity reactions to trimethoprim-sulfamethoxazole]. Tanabe K; Nakagawa A; Kimura S; Mitamura K; Shimada K; Mori S; Wakabayashi T; Inagaki M; Miura T Kansenshogaku Zasshi; 1988 Feb; 62(2):180-4. PubMed ID: 3137297 [No Abstract] [Full Text] [Related]
40. Failure of pentamidine as prophylaxis for Pneumocystis carinii pneumonia in HIV-infected children. Schuval SJ; Bonagura VR Arch Pediatr Adolesc Med; 1994 Aug; 148(8):876-9. PubMed ID: 8044270 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]